Ophthalmic Devices Market size is expected to be worth around USD 80.4 Bn by 2033 from USD 50.3 Bn in 2023, growing at a CAGR of 4.8%.

Snapshot img

Ophthalmology Devices Market Size 2025-2029

The ophthalmology devices market size is forecast to increase by USD 22.77 billion, at a CAGR of 4.9% between 2024 and 2029.

The market is driven by the escalating prevalence of ophthalmic diseases, fueling the demand for advanced diagnostic and therapeutic devices. This trend is further amplified by the rising medical tourism for affordable ophthalmology surgeries in developing countries, offering cost advantages to patients. However, the market faces significant challenges, including the high cost of ophthalmic devices and limited reimbursement policies, which may hinder market growth for some players.
Companies seeking to capitalize on this market's opportunities must focus on developing cost-effective solutions and navigating reimbursement complexities to maintain a competitive edge. Additionally, investments in research and development to introduce innovative devices and technologies will be crucial for market differentiation and long-term success. Furthermore, the integration of artificial intelligence (AI) in ophthalmology, including retinal imaging analysis and ocular inflammation diagnostics, is revolutionizing disease detection and treatment.

What will be the Size of the Ophthalmology Devices Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

The market continues to evolve, driven by advancements in technology and increasing demand for early disease detection and improved vision correction. Intraocular lenses and laser refractive surgery have revolutionized cataract treatment, leading to a significant increase in surgical success rates. For instance, the number of refractive error corrections performed annually has risen by 15% in the past decade. Ophthalmic viscoelastic devices, optical biometry systems, and optical coherence tomography are essential tools in these applications, providing accurate and detailed imaging for precise diagnosis.
Ocular prosthesis design, glaucoma diagnostic tools, and ophthalmic surgical instruments are other key market segments, benefiting from advancements in materials, such as ocular implant materials, and technologies, like phacoemulsification technology and microincision cataract surgery. Innovations in retinal imaging technology, intravitreal injection systems, and vitreoretinal surgery instruments are further enhancing the market's dynamism. Vision correction technology, such as corneal topography mapping and refractive error correction, is another area of significant growth, with a focus on minimally invasive procedures and personalized treatments.
The integration of artificial intelligence and machine learning algorithms is further driving innovation, enabling more accurate diagnoses and customized treatment plans. In summary, the market is characterized by continuous innovation and growth, with applications spanning early disease detection, vision correction, and surgical interventions. The integration of advanced technologies and materials is transforming diagnostic and therapeutic processes, leading to improved patient outcomes and enhanced quality of care.

How is this Ophthalmology Devices Industry segmented?

The ophthalmology devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Vision care
  Ophthalmology surgical devices
  Ophthalmology diagnostic devices


End-user

  Hospitals and eye clinics
  Academic and research laboratories
  Others


Application

  Cataract surgery
  Diagnosis and monitoring
  Glaucoma treatment
  Vitreo-retinal disorder management
  Refractive error correction


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    Spain
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The Vision care segment is estimated to witness significant growth during the forecast period. Intraocular lenses, a type of lens implanted in the eye during cataract surgery, are experiencing significant advancements, with innovations in materials such as silicone and acrylic. Laser refractive surgery, like LASIK, continues to correct refractive errors without the need for spectacles or contact lenses. Diabetic retinopathy screening, using technologies like optical coherence tomography and automated perimetry systems, is crucial for early detection and treatment. Remote patient monitoring, enabled by teleophthalmology platforms, allows for continuous monitoring of eye health. Ophthalmic viscoelastic devices, used during cataract surgery to maintain the shape of the eye, are essential for successful procedures. Refractive error correction, through methods like phacoemulsification technology and in

The United Kingdom Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

The global ophthalmic devices market size reached USD 28.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033. The market is propelled by the expanding geriatric population, rising prevalence of eye ailments, and the growing medical tourism sector which is driving innovation and investment in advanced eye care technologies.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product type, application, and end use.

Ophthalmic Devices Market is projected to reach 83.33 billion by 2033, growing at a CAGR of 6.5% from 2025-2033.

The global Ophthalmic Devices market is expected to grow from in 2024 to by 2032, driven by a CAGR of 7.13%.

The India Ophthalmology Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

The ophthalmic diagnostic equipment market is expected to grow from USD 3.56 billion in 2025 to USD 5.02 billion by 2035. The market is poised to expand at a 3.5% CAGR during the forecast period.

Ophthalmic Diagnostic Equipment Market Analyzed by Top Investment Segments

Analyzing Top Countries Producing and Distributing Ophthalmic Diagnostic Equipment

The United States Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

The size of the India Ophthalmology Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 7.30% during the forecast period. Indian Ophthalmology Devices Market: Among the rapidly growing products in the health industry, the market for ophthalmology devices is growing due to soaring disposable incomes and increasing eye diseases, coupled with rising awareness levels for eye care. Medical instruments and technologies used for diagnosis, treatment, and management of various eye conditions come under the umbrella of ophthalmology devices. These devices include intraocular lenses (IOLs), diagnostic equipment that spans from OCT, to fundus cameras and visual field analyzers, surgical instruments that consist of phacoemulsifiers and laser systems, contact lenses, and ophthalmic drugs. These include a wide variety of diseases that are addressed by ophthalmology, devices that include cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive errors. For example, IOLs are implanted in cataract surgeries to replace the cloudy lens and restore one's vision. Diagnostic equipment helps to make early diagnoses and monitor the diseases of the eye so that appropriate measures are taken in time. Operations are carried out with surgical instruments, which have made operations practically painless with minimal invasion, preventing a longer recovery time and improved patient outcome. Contact lenses correct what is commonly termed as refractory errors: myopia, hypermetropia, and astigmatism. Ophthalmic drugs treat conditions such as dry eye syndrome and infections where the eyes are uncomfortable and unhealthy, or glaucoma. Recent developments include: June 2022: LUMIBIRD opened its new Indian subsidiary in Mumbai: Lumibird Medical India. This company aims to boost the sales of Quantel Medical and Ellex products in India which has a vast range of ultrasound platforms, ophthalmic lasers and equipment for the diagnosis and treatment of dry eye disease., January 2022: Alcon launched the presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology, the AcrySof IQ Vivity IOL (Vivity), in India.. Key drivers for this market are: Growth in Cataract Volume, Technological Advancements in the Field of Ophthalmology; Rising Geriatric Population. Potential restraints include: Shortage of Skilled Professionals, Low Awareness About Eye-related Diseases. Notable trends are: The Glaucoma Surgery Devices Segment is Expected to Hold A Significant Share in the Market Over the Forecast Period.

According to Cognitive Market Research, the global ophthalmology devices market size is USD 7.0 million in 2024 and will expand at a compound annual growth rate (CAGR) of 4.92% from 2024 to 2031. Market Dynamics of Ophthalmology Devices Market

Key Drivers for Ophthalmology Devices Market

Rise is Cases for Ophthalmic Diseases - Ophthalmic illnesses, including glaucoma and cataracts, are becoming more common, which is a major driver fueling the expansion of the ophthalmology devices market. With the growing need for contact lenses and cutting-edge equipment, these devices are poised to dominate the industry. The market for microinvasive glaucoma surgical implants is expanding at a faster rate than any other treatment. Common eye problems like diabetic retinopathy, cataracts, age-related macular degeneration, and all the other ophthalmic illnesses are expected to fuel market expansion. Rising consumer awareness of ophthalmology devices and an uptick in research and development efforts to create new ones are anticipated to drive the market's expansion.

Key Restraints for Ophthalmology Devices Market

The absence of knowledge on eye-related illnesses is expected to slow down the market's growth. A lack of qualified individuals is expected to pose a problem for the ophthalmology equipment industry. Introduction of the Ophthalmology Devices Market

Ophthalmic devices are medical tools commonly used for diagnosing eye conditions, correcting visual problems, and performing surgeries. Their advantages are becoming more well-known and popular due to the increasing number of people suffering from ophthalmic ailments like glaucoma, cataracts, and others that affect eyesight. The global ophthalmic devices market is expected to experience expansion due to the rising demand for high-quality eye care and the increasing number of procedures meant to correct visual problems. The developing world's improving healthcare infrastructure, along with the rising demand for and demand for less-invasive processes, is anticipated to enhance the expansion of the market.

The UK ophthalmology devices market size was valued at USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 5% during the forecast period, 2023–2031. The growth of market is attributed to increasing frequency of eye-related illnesses & disorders, as well as increased public awareness.

Ophthalmology is a medical specialty that deals with the anatomy, function, and illnesses of eyes. Surgical, diagnostic, and vision correction devices are the three basic categories of ophthalmic devices depending on their function. These devices gain rising importance & adoption due to more prevalence of different ophthalmic diseases such as cataract, glaucoma, and other vision-related issues.

The Covid-19 pandemic affected the demand and supply of the UK ophthalmology devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Due to lockdown, the ophthalmology diagnostics clinics are closed and the surgeries are postponed which is expected to limit the market growth.

UK Ophthalmology Devices Market Trends, Drivers, Restraints, and Opportunities

• 
  

  New ophthalmology equipment and sophisticated methods are favored by the development of new ophthalmology devices and procedures, which is projected to drive the market.

  
  


• 
  

  Rising prevalence of eye diseases and demographic shift, is projected to boost the market.

  
  


• 
  

  Ophthalmic procedures and their risks, are projected to hinder the market growth.

  
  </

Global Ophthalmology Devices market size earned around $40.38 Bn in 2023 and is expected to reach $65.49 Bn by 2032, with a projected CAGR of 5.52%.

The Spain Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

Ophthalmology Devices Market Outlook

The global ophthalmology devices market size was valued at approximately USD 56 billion in 2023 and is projected to reach about USD 95 billion by 2032, exhibiting a compound annual growth rate (CAGR) of around 6.2% during the forecast period. The rapid growth of this market can be attributed to the increasing prevalence of ocular diseases, technological advancements in ophthalmic devices, and a growing aging population worldwide. Factors such as rising incidences of age-related macular degeneration, diabetic retinopathy, cataracts, and glaucoma are pushing the demand for advanced diagnostic and surgical solutions, thereby propelling the market growth of ophthalmology devices.

The aging global population is one of the primary drivers of the ophthalmology devices market. As life expectancy increases, the prevalence of age-related eye disorders such as cataracts and glaucoma also rises, creating a substantial demand for both diagnostic and surgical ophthalmic devices. Moreover, changing lifestyle habits, such as increased screen time and exposure to digital screens, have led to a surge in vision-related issues among younger populations, further boosting the demand for ophthalmology solutions. The surge in demand is accelerated by increased healthcare expenditure, innovations in healthcare infrastructure, and the growing awareness regarding eye health which is encouraging regular eye check-ups.

Technological advancements in ophthalmology devices stand as another significant growth factor for the market. The integration of artificial intelligence, machine learning, and robotic systems into ophthalmic devices is revolutionizing the industry by enhancing the accuracy, safety, and efficiency of ophthalmic procedures. Innovations such as femtosecond laser-assisted cataract surgery, advanced intraocular lenses, and minimally invasive surgical techniques are gaining traction, providing faster recovery times and better visual outcomes for patients. These technological strides not only improve patient outcomes but also expand the capabilities of ophthalmology professionals, fueling market expansion.

The robust emergence of teleophthalmology is another key growth factor, especially in remote and underserved regions. With the increasing adoption of digital health platforms, teleophthalmology provides a vital solution for patients who have limited access to in-person eye care services. This trend has been further accelerated by the COVID-19 pandemic, which necessitated the adoption of remote healthcare services globally. Teleophthalmology not only offers convenience but also ensures early detection and treatment of eye disorders, thereby contributing significantly to market growth.

Regionally, the ophthalmology devices market presents diverse dynamics. North America holds a dominant position due to its well-established healthcare infrastructure, high prevalence of eye disorders, and substantial investment in research and development. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by the burgeoning healthcare sector, rapidly aging population, and increasing awareness of eye health. Additionally, favorable government initiatives in emerging markets like India and China are set to boost the adoption of advanced ophthalmology devices. The European market, characterized by high healthcare expenditure and a strong focus on innovation, also remains a significant contributor to the global ophthalmology devices market.

Product Type Analysis

The ophthalmology devices market is broadly segmented into diagnostic and monitoring devices, surgical devices, and vision care devices. Diagnostic and monitoring devices encompass a range of equipment used to assess and diagnose eye conditions, including optical coherence tomography (OCT) machines, fundus cameras, and tonometers. These devices have seen significant growth due to escalating demand for early diagnosis and proactive management of ocular diseases. The continuous evolution in diagnostic technology, such as the incorporation of artificial intelligence for enhanced image recognition and interpretation, is expected to further drive market growth. Additionally, the increasing trend of personalized medicine is fostering innovation in diagnostic tools that allow for tailored treatment plans.

Surgical devices form a crucial segment within the ophthalmology devices market, comprising equipment used for various eye surgeries, such as phacoemulsification systems for cataract surgeries, vitrectomy machines for vitreoretinal procedures, and laser syst

Recent developments include: In September 2022, Centricity Vision Inc., a global ophthalmic technology company and ZEPTO IOL Positioning System developer launched ZEPTO Plus, a new, innovative addition to its handpiece portfolio., In July 2022, AbbVie and iSTAR Medical SA entered into a strategic partnership to further develop and commercialize iSTAR Medical's MINIject device. It is a minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma.. Key drivers for this market are: Increasing Prevalence of Eye Diseases, Technological Advancements in Ophthalmic Devices. Potential restraints include: Risk Associated with Ophthalmic Procedures and Poor Primary Healthcare Infrastructure. Notable trends are: Contact Lenses Segment is Expected to Witness Growth Over the Forecast Period.

The size of the South Korea Ophthalmic Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 4.20% during the forecast period. South Korea's ophthalmic devices market can be termed as a rapidly growing market. Major growth drivers for this market are an aging population, increasing prevalence of eye diseases, and rising disposable incomes. Ophthalmic devices are surgical instruments utilized in the diagnosis and treatment of eye disorders. The category encompasses numerous types of products. There are intraocular lenses, contact lenses, surgical instruments, diagnostic equipment, and laser systems. IOLs are implanted inside the eye in order to replace the natural lens in cataract patients. They are crucial in restoring the vision of the patients afflicted with cataract and enabling them to lead quality life. Contact lenses can be used in correcting conditions like myopia, hyperopia, and astigmatism. They offer an easy and relatively incognito alternate to eyeglasses. Most of the ophthalmic surgeries, including the delicate cataract surgery, glaucoma surgery, and even retinal surgery, are performed using surgical equipment. Various diagnostic equipment, like optical coherence tomography and fundus cameras, are directed towards studying the anatomy and physiology of the eye. Ophthalmologic therapies include laser corrective vision, treatment of glaucoma, and retinal surgery, for which laser systems are used. The ophthalmic devices market in South Korea shows both domestic and international companies. Local firms have been becoming increasingly competitive; mainly this has been brought about by technological advances and government support. Because the global companies like Johnson & Johnson, Alcon, and Zeiss have a huge presence in the market, with strong brand value, this market is expected to keep a growth trajectory for years to come, triggered by factors like growing awareness about eye care and governmental policies, not to mention the advancement in technology. Recent developments include: In July 2022, Baxter launched its Welch Allyn RetinaVue 100 Imager PRO in South Korea. The device was designed to make diabetic retinopathy screening simple and affordable in primary care settings., In May 2022, Visus Therapeutics Inc. and Zhaoke Ophthalmology Limited announced an exclusive licensing agreement to commercialize BRIMOCHOL PF and Carbachol PF in South Korea for the treatment of presbyopia.. Key drivers for this market are: Rising Burden of Eye Disorders, Technological Advancements. Potential restraints include: Risk Associated with Ophthalmic Procedures. Notable trends are: Lasers Segment is Expected to Show Better Growth during the Forecast Period.

United Kingdom Ophthalmology Devices Market was valued at USD 1.1 Billion in 2023 and is projected to reach USD 1.5 Billion by 2031, growing at a CAGR of 4.5% from 2024 to 2031.

United Kingdom Ophthalmology Devices Market: Definition/ Overview

Ophthalmology devices are medical instruments and technologies used for the diagnosis, treatment, and management of various eye conditions and diseases. These devices include surgical instruments (like lasers and cataract surgery tools), diagnostic tools (like OCT machines and tonometer’s), and therapeutic devices (like intraocular lenses and contact lenses). Hospitals, eye clinics, and outpatient centers are just a few of the healthcare facilities that use them. The rising incidence of eye conditions like cataracts, age-related macular degeneration, and diabetic retinopathy, along with technological developments for more precise diagnosis and less invasive treatments, are driving growth in the UK market for ophthalmology devices. The need for ophthalmology devices is also fueled by an aging population, increased knowledge of eye health, and the desire for better healthcare results.

China Ophthalmic Devices Market Outlook 2031:

The China ophthalmic devices market size was valued at USD 4.51 Billion in 2022 and is projected to reach USD 9.47 Billion by 2031, expanding at a CAGR of 8.59% during the forecast period 2023 - 2031. The growth of the market is attributed to the increasing prevalence of eye disorders and vision loss.

Ophthalmology is known to be a field of clinical science that handles function, structure, and several eye diseases. Ophthalmic devices are clinical instruments that analyze and treat conditions of eyes.

They can be used with an eye-care professional’s supervision, but some can also be self-administered by patients as part of home care. These ranges from simple tonometers to laser surgical systems for correcting eyesight issues such as myopia and hypermetropia, utilized during medical procedures along different items.



At the point when the World Health Organization (WHO) declared Covid-19 as an overall pandemic in March 2020, routine medical care arrangements were kept away to keep patients from getting the infection, and ophthalmology services were especially affected.



Numerous strategies are elective and most patients are older and in risk of experiencing Covid-19 side effects. As the pandemic proceeds with an anticipated ‘third wave,’ ophthalmologists are endeavoring to reduce the backlog of strategies while adhering to safety protocols. The Covid-19 pandemic can prompt a long-term change in the ophthalmology market.

Ophthalmic Devices Market Trends, Drivers, Restraints, and Opportunities

• Growing geriatric population is estimated to accelerate the growth of the market.


• <span style="font-size:11pt

The Brazilian ophthalmic devices market is anticipated to reach a valuation of million by 2033, exhibiting a CAGR of 5.8% during the forecast period of 2023-2030. The market's growth is primarily attributed to increasing prevalence of eye diseases, rising disposable income, and technological advancements in ophthalmic devices. Brazil is home to a substantial population with age-related eye conditions like cataracts and glaucoma, which has led to a surge in demand for surgical and diagnostic ophthalmic devices. Additionally, the country's expanding healthcare infrastructure and favorable government policies supporting the healthcare sector are fostering market growth. Key drivers of the Brazilian ophthalmic devices market include the increasing incidence of eye diseases, rising healthcare expenditure, and advancements in ophthalmic technologies. The market is segmented into surgical devices, diagnostic and monitoring devices, and vision correction devices. Surgical devices hold the largest market share due to the high prevalence of eye surgeries, such as cataract and refractive surgeries. Diagnostic and monitoring devices are also witnessing significant growth due to the rising demand for early detection and management of eye diseases. Technological advancements, such as the development of intraocular lenses and laser systems, are further driving market expansion. Recent developments include: In July 2021, Johnson & Johnson Vision announced the global availability of the VERITAS Vision System, next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency, and comfort., In July 2021, CooperVision has teamed up with Plastic Bank, which operates in Haiti, Brazil, Indonesia, the Philippines, and Egypt to transform the clariti 1-day lens family into the first net plastic-neutral contact lens in the United States.. Key drivers for this market are: Increasing Prevalence of Eye Disease, Increasing Geriatric Population. Potential restraints include: Shortage of Skilled Professionals. Notable trends are: Contact Lenses Segment is Expected to Witness Growth Over the Forecast Period.